Focused & Specialized
Clinical trial sponsors working in oncology, hematology, gastroenterology (GI), infectious diseases (ID), neurology, and many rare diseases, rely on PSI’s guidance and experience, knowing we’re specialized and committed to delivering some of the most complex clinical projects in the industry.
Oncology
Breast cancer, lung cancer, prostate cancer, colorectal cancer, ovarian cancer, and other oncology indications
Learn more
Gastroenterology (GI)
Inflammatory bowel diseases, Crohn’s disease, ulcerative colitis, and other GI indications
Learn more
Hematology
Multiple myeloma, lymphomas, leukemias, hemophilia, and other bleeding disorders
Learn more
Cell & Gene Therapy
CAR-T, gene editing, stem cell therapy, and immunotherapy
Learn more
Neurology
Multiple sclerosis, spasticity, stroke, Alzheimer’s, Parkinson’s, and other neurological indicationsÂ
Learn more
Infectious Diseases
UTI, CAP/VAP/HAP, skin infections, bacteremia, fungal diseases, sepsis, hepatitis, and other infectious diseasesÂ
Learn more
Radiopharmaceuticals
Oncology, neurology, and other therapeutic areas with a broad range of isotopes and targetsÂ
Learn more
Respiratory
COPD, IPF, asthma, pneumonia, and other respiratory diseases
Learn more
Other Therapeutic Areas
Allergy, immunology, rheumatology, endocrine and metabolic diseases, cardiology, nephrology and urology, and other indications
Learn more
PSI was flexible to meet the various challenges in clinical trial conduct. The rapid enrollment of patients and the quick study close out allowed on-time study completion.
Chief Medical Officer



Case Study: Phase 3 Radiopharmaceutical Clinical Trial in Oncology